Seeking Alpha

Alexion Pharmaceuticals Inc. (ALXN)

()

News & PR
Market Currents

Buzz
Twitter: ALXN

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

21 Breakout Stocks to Watch, And How to Generate Income with Apple LEAP Options

Oct 23 • Marco Hickey • 1 Comment
Pundits Are Wrong: Healthcare Reform Will Increase Profits

Sep 17 • Todd Campbell • 24 Comments
Ken Griffin's Citadel Fund: Options Eye Candy

Sep 10 • Market Folly • 2 Comments
38 Reasons the Google IPO Isn't the Big Deal Some Are Making It Out to Be

Aug 19 • Bespoke Investment Group • 12 Comments
Breakout Stocks on Huge Volume: Three Option Trades

Jul 27 • Marco Hickey • 4 Comments
Biotech ETFs Surge Again on M&A News

Jul 24 • Michael Johnston • Comment!
Wall Street Breakfast: Must-Know News

Jul 23 • SA Editor Rachael Granby • 18 Comments
15 Necessary Components for the Next Leg Higher

Jul 21 • The Inflection Point • 5 Comments
Is IBB the Best Biotech ETF?

Jul 2 • Don Dion • 1 Comment
30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch

Jun 28 • Marco Hickey • 1 Comment
Wall Street Breakfast: Must-Know News

Apr 23 • SA Editor Rachael Granby • 9 Comments
Where Might Genentech Investors Redeploy $47B?

Mar 16 • Michael Becker • 2 Comments
Reversal of Stem Cell Research Ban: 13 Stocks to Benefit

Mar 12 • Brian Dean • 9 Comments
12 Stem Cell Stocks - Updated

Mar 9 • Stockerblog • 8 Comments
Biopharma: Instead of M&A, Think P&A

Mar 4 • Mike Huckman • 2 Comments
IBB: Newfound Stability Lures Biotech Investors

Feb 18 • Don Dion • Comment!
I Like Haemonetics While Cognizant and Alexion Breed Concern

Feb 16 • Robert Freedland • Comment!
Wall Street Breakfast: Must-Know News

Feb 12 • SA Editor Rachael Granby • 14 Comments
Hedge Fund Portfolio Tracking: Citadel Investment Group (Ken Griffin), Q3 2008

Jan 13 • Market Folly • 6 Comments
Hedge Fund Tracking: Pequot Capital Management (Art Samberg), Q3 2008

Dec 30, 2008 • Market Folly • Comment!
Even Fatter Yields for Pfizer; M&A Targets in the Sector

Oct 17, 2008 • Mike Havrilla • 3 Comments
Stocks Potentially Impacted by SEC's Enforcement of Regulation SHO

Sep 18, 2008 • J Clinton Hill • 6 Comments
5 Potential Buyout Targets in Biotech - Barron's

Aug 17, 2008 • SA Editor Rachael Granby • 9 Comments
Tuesday Options Outlook: MER, C, CSC, TIE, PWAV, GPS, ALXN, ELNK

Jul 29, 2008 • Andrew Wilkinson • Comment!
A Biotech Bloom in July

Jul 28, 2008 • Option Dragon • 10 Comments
Biotech Buying Binge About to Begin?

Jul 23, 2008 • Mike Havrilla • 3 Comments
Q1 Earnings 'Triple Plays'

Jul 9, 2008 • Bespoke Investment Group • 5 Comments
Will M&A Activity Boost PowerShares Dynamic Biotech & Genome ETF?

May 9, 2008 • Don Dion • 1 Comment
Alexion Pharma: Bounce Play?

Feb 21, 2008 • Notable Calls • Comment!
Top 7 BioPharma & Pharma Innovations of 2007

Dec 17, 2007 • Fredric Cohen, M.D. • 1 Comment
Nine Stem Cell Stocks to Add to Your Portfolio

Oct 2, 2007 • Stockerblog • 2 Comments
Companies With The Most Analyst Attention & Affection

Jun 5, 2007 • Bespoke Investment Group • 3 Comments
Loeb's Third Point Releases 13F Filing, Shows a Number of New Positions

May 17, 2007 • Lon Juricic • Comment!
Alexion Pharmaceuticals: Costs of Healthcare Rise to the Extreme

Mar 30, 2007 • Chad Brand • Comment!
Conference Call With Alexion Leaves Credit Suisse Analyst Speechless

Mar 28, 2007 • Fredric Cohen, M.D. • 1 Comment
Biotech Day in Review: AtheroGenics Tumbles on Drug Test Failure

Mar 20, 2007 • Centient Biotech Investor • Comment!
Investing in Stem Cell Stocks: Growth Industry of the Future?

Feb 21, 2007 • Stockerblog • 12 Comments
Chart: Biotech Stocks - Annual Earnings Growth

Jul 27, 2006 • Robert Zenilman • Comment!
Chart: Biotech Stocks - Quarterly Earnings Growth

Jul 20, 2006 • Robert Zenilman • Comment!
Chart: Biotech Stocks - Annual Revenue Growth (Last 12 Months Reported)

Jul 13, 2006 • Robert Zenilman • Comment!
Chart: Biotech Stocks - Quarterly Revenue Growth

Jul 6, 2006 • Robert Zenilman • Comment!

Alexion Pharmaceuticals Inc. (ALXN)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers